Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Hansoh signs $690M ADC pact with fellow Chinese biotech Biotheus
Hansoh has secured a license to use Biotheus’ bispecific antibody PM1080/HS-20117 in developing antibody-drug conjugates.
James Waldron
Mar 15, 2024 8:35am
Astellas puts the cork back in $350M Xork deal with Cartesian
Mar 14, 2024 10:41am
AstraZeneca inks $800M buyout to snag phase 3 rare disease drug
Mar 14, 2024 9:47am
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Mar 13, 2024 10:31am
Novartis hits the cGAS, taking up option to buy IFM unit
Mar 13, 2024 9:01am
Silence loses Mallinckrodt collab, wins in cardiovascular ph. 2
Mar 13, 2024 8:54am